Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Diabetes Therapy

Issue 1/2013

Content (12 Articles)

Open Access Review

Glucose Meters with Built-In Automated Bolus Calculator: Gadget or Real Value for Insulin-Treated Diabetic Patients?

Ides M. Colin, Isabelle Paris

Open Access Review

Management of Type 2 Diabetes in Older People

Ahmed H. Abdelhafiz, Alan J. Sinclair

Open Access Original Research

A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice

Marc Evans, Phil McEwan, Richard O’Shea, Lindsay George

Open Access Original Research

Impact of Voglibose on the Pharmacokinetics of Dapagliflozin in Japanese Patients with Type 2 Diabetes

Akira Imamura, Masahito Kusunoki, Shinya Ueda, Nobuya Hayashi, Yasuhiko Imai

Open Access Original Research

Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom

Jason Gordon, Marc Evans, Phil McEwan, Steve Bain, Jiten Vora

Open Access Original Research

Omitting Follow-up Food After Initial Hypoglycaemic Treatment Does not Increase the Likelihood of Repeat Hypoglycaemia

Sally Vindedzis, Beryl Marsh, Jill Sherriff, Satvinder Dhaliwal, Kim Stanton

Open Access Original Research

Safety and Effectiveness of Insulin Detemir in Different Age-Groups in the A1chieve Study

Rachid Malek, Guillermo Gonzalez-Galvez, Nabil El Naggar, Siddharth Shah, Vinay Prusty, Leon Litwak

Open Access Original Research

Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries

Philip Home, Jihad Haddad, Zafar Ahmed Latif, Pradana Soewondo, Youcef Benabbas, Leon Litwak, Serdar Guler, Jian-Wen Chen, Alexey Zilov

Open Access Original Research

Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A1chieve Study Results

Zafar A. Latif, Zanariah Hussein, Leon Litwak, Nabil El Naggar, Jian-Wen Chen, Pradana Soewondo

Open Access Original Research

Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies

Samuel S. Engel, Elizabeth Round, Gregory T. Golm, Keith D. Kaufman, Barry J. Goldstein

Open Access Original Research

A Retrospective Audit of Type 2 Diabetes Patients Prescribed Liraglutide in Real-Life Clinical Practice

Ciara M. Mulligan, Roy Harper, Janet Harding, Werner McIlwaine, Ann Petruckevitch, Darren M. McLaughlin

Open Access Original Research

Safety and Effectiveness of Bolus Insulin Aspart in People with Type 2 Diabetes: A1chieve Sub-Analysis

Hoosen Randeree, Andreas Liebl, Issam Hajjaji, Mohammad Khamseh, Lenita Zajdenverg, Jian-Wen Chen, Jihad Haddad

Dec 12
Issue: 1/2012
Dec 13
Issue: 2/2013

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits